Liu et al. have demonstrated using CRISPR/Cas9 that WHSC1 inhibits colon cancer cell proliferation, boosts drug sensitivity, and reduces metastatic ability in colon cancer cells (Liu H. H. et al., 2021). Here, NSD2 is linked to colonic neoplasm.